Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flouro-Gem as First Line Treatment of Metastatic Pancreatic Adenocarcinoma
NCT04769414Phase 2Completed
- Sponsor
- Menoufia University
- Start
- Feb 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, fluorouracil in pancreatic adenocarcinoma (PDAC), sponsored by Menoufia University. Started Feb 2021; status: completed.
02
Drugs
gemcitabinefluorouracil
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04769414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04769414.